SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-001229
Filing Date
2017-07-19
Accepted
2017-07-19 17:24:20
Documents
1
Period of Report
2017-07-17

Document Format Files

Seq Description Document Type Size
1 form4-07192017_020709.html 4  
1 form4-07192017_020709.xml 4 3967
  Complete submission text file 0001415889-17-001229.txt   5381
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 17972903